| For: | MacIsaac RJ, Jerums G, Ekinci EI. Effects of glycaemic management on diabetic kidney disease. World J Diabetes 2017; 8(5): 172-186 [PMID: 28572879 DOI: 10.4239/wjd.v8.i5.172] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v8/i5/172.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Richard J. MacIsaac, George Jerums, Elif I. Ekinci. Glycemic Control as Primary Prevention for Diabetic Kidney Disease. Advances in Chronic Kidney Disease 2018; 25(2) doi: 10.1053/j.ackd.2017.11.003
|
| 3 |
Farhan Khan, Tanjil Hussain, Taha Zahid Chaudhry, FNU Payal, Abdullah Shehryar, Abdur Rehman, Afif Ramadhan, Muhammad Tassaduq Hayat, Muath M Dabas, Mustafa Khan. Comparing the Efficacy and Long-Term Outcomes of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Metformin, and Insulin in the Management of Type 2 Diabetes Mellitus. Cureus 2024; doi: 10.7759/cureus.74400
|
| 4 |
Anton I Korbut, Vadim V Klimontov, Ilya V Vinogradov, Vyacheslav V Romanov. Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes. World Journal of Diabetes 2019; 10(11): 517-533 doi: 10.4239/wjd.v10.i11.517
|
| 5 |
Juan F. Navarro-González, Leopoldo Perez de Isla, Gloria Cánovas Molina, Miguel Ángel Brito-Sanfiel, David Emilio Barajas Galindo, Luís Ángel Cuellar Olmedo, Dídac Mauricio, Santiago Tofé Povedano, José Antonio Balsa Barro, Matilde Rubio Almanza, José Juan Aparicio Sánchez, Miren Sequera Mutiozabal, Belén Pimentel, Ana Pérez Domínguez, Carlos Arias-Cabrales, Victor Fanjul, Antonio Jesús Blanco-Carrasco, Juan Francisco Merino Torres. Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data. Kidney Diseases 2025; 12(1) doi: 10.1159/000547604
|
| 6 |
Marc Evans, Angharad R. Morgan, Dipesh Patel, Ketan Dhatariya, Sharlene Greenwood, Philip Newland-Jones, Debbie Hicks, Zaheer Yousef, Jim Moore, Bethany Kelly, Sarah Davies, Umesh Dashora. Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications. Diabetes Therapy 2021; 12(1) doi: 10.1007/s13300-020-00963-2
|
| 7 |
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds. The Natural Products Journal 2025; 15(7) doi: 10.2174/0122103155306808240705040740
|
| 8 |
Mengyu Zhang, Sudi Zhu, Di Hu, Wenqiang Fu, Henggui Hu, Yuanyuan Xu, Kaixuan Zhang, Heng Tang, Xiaolei Du. Developing and validating a clinlabomics-based machine-learning model for early detection of occult diabetic kidney disease: implications for primary care screening. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1835866
|
| 9 |
Teklewoini Mariye Zemicheal, Degena Bahrey Tadesse, Hagos Tasew Atalay, Girmay Teklay Weldesamuel, Gebrewahd Bezabh Gebremichael, Haben Nuguse Tesfay, Teklehaimanot Gereziher Haile. Determinants of Diabetic Nephropathy among Diabetic Patients in General Public Hospitals of Tigray, Ethiopia, 2018/19. International Journal of Endocrinology 2020; 2020 doi: 10.1155/2020/6396483
|
| 10 |
Andreas S. Papazoglou, Anastasios Kartas, Dimitrios V. Moysidis, Christos Tsagkaris, Stavros P. Papadakos, Alexandra Bekiaridou, Athanasios Samaras, Efstratios Karagiannidis, Marios Papadakis, George Giannakoulas. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation. Cardiovascular Diabetology 2022; 21(1) doi: 10.1186/s12933-022-01473-0
|
| 11 |
Lucas Opazo-Ríos, Yenniffer Sanchez Matus, Raúl R Rodrigues-Díez, Daniel Carpio, Alejandra Droguett, Jesús Egido, Carmen Gomez-Guerrero, Sergio Mezzano. Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes. BMJ Open Diabetes Research & Care 2020; 8(1) doi: 10.1136/bmjdrc-2020-001242
|
| 12 |
Pengyu Tao, Jing Ji, Qian Wang, Mengmeng Cui, Mingfeng Cao, Yuzhen Xu. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1080456
|
| 13 |
Stephanie A. Eid, Phillipe D. O'Brien, Katharina H. Kretzler, Dae‐Gyu Jang, Faye E. Mendelson, John M. Hayes, Andrew Carter, Hongyu Zhang, Subramaniam Pennathur, Frank C. Brosius, Emily J. Koubek, Eva L. Feldman. Dietary interventions improve diabetic kidney disease, but not peripheral neuropathy, in a db/db mouse model of type 2 diabetes. The FASEB Journal 2023; 37(8) doi: 10.1096/fj.202300354R
|
| 14 |
Palita Chittinandana, Pongsathorn Gojaseni, Anan Chuasuwan, Rattinan Singprasert, Worawon Chailimpamontree, Anutra Chittinandana. Major adverse kidney events in multidisciplinary chronic kidney disease care compared with usual outpatient care: a propensity score matched analysis. Journal of Nephrology 2024; 37(8) doi: 10.1007/s40620-024-01994-9
|
| 15 |
Hong Lian, Hongshi Wu, Jie Ning, Diaozhu Lin, Chulin Huang, Feng Li, Ying Liang, Yiqin Qi, Meng Ren, Li Yan, Lili You, Mingtong Xu. The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.673976
|
| 16 |
Wan-Ching Lo, Yi-Ju Huang, Ya-Lin Tasi, Jo-Fan Chen, Hsiu-Chin Mai, Yu-Ling Hung, Yi-Hui Chio, Chiu-Yueh Chen, Yu-Lun Ou, Szu-Chia Chen. Analysis of the association of multidisciplinary team care and education intervention in patients with early-stage diabetic kidney disease in Taiwan. Endocrine Journal 2026; 73(4) doi: 10.1507/endocrj.EJ25-0418
|
| 17 |
Marija Vukmirović Papuga, Zoran Bukumirić, Branislava Ilinčić, Romana Mijović, Tanja Šašić Ostojić, Radmila Žeravica. Serum Uromodulin, a Potential Biomarker of Tubulointerstitial Damage, Correlates Well with Measured GFR and ERPF in Patients with Obstructive Nephropathy. Medicina 2022; 58(12) doi: 10.3390/medicina58121729
|
| 18 |
Mitku Mammo Taderegew. Assessment of renal impairment using estimated glomerular filtration rate among type 2 diabetes mellitus patients in North-East Ethiopia: a cross-sectional study. Journal of Diabetes & Metabolic Disorders 2020; 19(2) doi: 10.1007/s40200-020-00680-4
|
| 19 |
Xiao zhu Liu, Minjie Duan, Hao dong Huang, Yang Zhang, Tian yu Xiang, Wu ceng Niu, Bei Zhou, Hao lin Wang, Ting ting Zhang. Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1184190
|
| 20 |
Jing Ji, Pengyu Tao, Qian Wang, Mengmeng Cui, Mingfeng Cao, Yuzhen Xu. Emodin attenuate diabetic kidney disease by inhibiting ferroptosis via up regulating Nrf2 expression. Aging 2023; doi: 10.18632/aging.204933
|
| 21 |
Wendy A Davis, Aron Chakera, S A Paul Chubb, Timothy M E Davis. Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2. Journal of the Endocrine Society 2025; 9(6) doi: 10.1210/jendso/bvaf062
|
| 22 |
I. Löffler, G. Wolf. Pathophysiologie der diabetischen Nephropathie. Der Nephrologe 2017; 12(6) doi: 10.1007/s11560-017-0191-5
|
| 23 |
David Chen, Jordan Fulcher, Emma S. Scott, Alicia J. Jenkins. Precision Medicine in Diabetes. 2022; doi: 10.1007/978-3-030-98927-9_1
|
| 24 |
N. Torkamani, L. Churilov, R. Robbins, G. Jerums, V. Beik, N. Radcliffe, S. Patterson, R. Bellomo, J. Burns, G.K. Hart, Q. Lam, D.A. Power, RJ MacIsaac, D.F. Johnson, J. Zajac, E.I. Ekinci. Diabetes and higher HbA1c levels are independently associated with adverse renal outcomes in inpatients following multiple hospital admissions. Journal of Diabetes and its Complications 2020; 34(1) doi: 10.1016/j.jdiacomp.2019.107465
|
| 25 |
Leo Yosdimyati Romli. The Relationship between Microalbumin Levels and HbA1c in People at Risk for Type 2 Diabetes Mellitus. Medicra (Journal of Medical Laboratory Science/Technology) 2021; 4(2) doi: 10.21070/medicra.v4i2.1612
|
| 26 |
Vanja Kosjerina, Bendix Carstensen, Hanan Amadid, Dorte Vistisen. Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort study. Diabetologia 2023; 66(10) doi: 10.1007/s00125-023-05971-y
|
| 27 |
Stephanie Notaras, Leanne Galea, Paul Lee, May Mak, Kelly Lambert, Angela Makris. The association between dietetic consultation and time to dialysis for patients attending a pre‐dialysis clinic: A retrospective cohort study. Nephrology 2020; 25(5) doi: 10.1111/nep.13639
|
| 28 |
Shi Shu, Yue Zhang, Qian Wang, Pengyu Tao, Zhijie Li, Zhongju Xu, Haiying Lu, Lin Shi, Min Tang. Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-β/Smad2/3 Pathway. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/5063636
|
| 29 |
Lois A. Balmer, Rhiannon Whiting, Caroline Rudnicka, Linda A. Gallo, Karin A. Jandeleit, Yan Chow, Zenia Chow, Kirsty L. Richardson, Josephine M. Forbes, Grant Morahan. Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease. Kidney International 2019; 96(4) doi: 10.1016/j.kint.2019.04.031
|
| 30 |
Chunmei Xu, Huikai Miao, Xiaoxuan Chen, Haiqing Zhang. Cellular mechanism of action of forsythiaside for the treatment of diabetic kidney disease. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1096536
|
| 31 |
Yu Liang, Zhonggao Xu, Wanning Wang. Oxidative balance score is associated with the risk of diabetic kidney disease in patients with type 2 diabetes mellitus: evidence from NHANES 2007–2018. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1499044
|
| 32 |
Rodney Kwok, Kartik Kishore, Tina Zafari, Digsu N. Koye, Mariam Hachem, Ian H. de Boer, Tae-Dong Jeong, Won-Ki Min, Esteban Porrini, Petter Bjornstad, Yih Chung Tham, Richard J. MacIsaac, Leonid Churilov, Elif I. Ekinci. RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes. Diabetes Research and Clinical Practice 2026; 233 doi: 10.1016/j.diabres.2026.113137
|
| 33 |
Lingyun Kong, Sofianos Andrikopoulos, Richard J MacIsaac, Laura K Mackay, David J Nikolic‐Paterson, Niloufar Torkamani, Neda Zafari, Evelyn C S Marin, Elif I Ekinci. Role of the adaptive immune system in diabetic kidney disease. Journal of Diabetes Investigation 2022; 13(2) doi: 10.1111/jdi.13725
|
| 34 |
Adrian LIEW, Sunita BAVANANDAN, Narayan PRASAD, Muh Geot WONG, Jer Ming CHANG, Somchai EIAM‐ONG, Chuan‐Ming HAO, Chiao Yuen LIM, Soo Kun LIM, Kook‐Hwan OH, Hirokazu OKADA, Paweena SUSANTITAPHONG, Aida LYDIA, Huong Thi Bich TRAN, Russell VILLANUEVA, See Cheng YEO, Sydney C.W. TANG. ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE. Nephrology 2020; 25(S2) doi: 10.1111/nep.13785
|
| 35 |
Ji-qin XIANG, Wen-jing WEI, Mei-hua LIAO, Ke-xing ZHANG, Ying-qi ZHOU, Wen-jie ZHANG, Chun-zhi TANG, Neng-gui XU, Rong-rong TAO. Mitigation of renal microvascular injury in diabetic kidney disease model mice by electroacupuncture. World Journal of Acupuncture - Moxibustion 2023; 33(3) doi: 10.1016/j.wjam.2023.05.004
|
| 36 |
Agata Foryciarz, Fernando Alarid-Escudero, Gabriela Basel, Marika M. Cusick, Robert L. Phillips, Andrew Bazemore, Alyce S. Adams, Sherri Rose. A Microsimulation-Based Approach for Mitigating Societal Bias in Chronic Kidney Disease Data. Medical Decision Making 2026; doi: 10.1177/0272989X261432162
|
| 37 |
Ang Li, Yayuan Mei, Meiduo Zhao, Jing Xu, Runkui Li, Jiaxin Zhao, Quan Zhou, Xiaoyu Ge, Qun Xu. Associations between air pollutant exposure and renal function: A prospective study of older adults without chronic kidney disease. Environmental Pollution 2021; 277 doi: 10.1016/j.envpol.2021.116750
|
| 38 |
A. Kathiraven, R. Srimathi, Kathiravan. M.K. Exploring the Relationship of DPP-IV Inhibitors in the treatment of Diabetes and Cardiovascular Disease. Research Journal of Pharmacy and Technology 2024; doi: 10.52711/0974-360X.2024.00555
|
| 39 |
Enrique Juan Díaz Greene, Roxana Sánchez Arreguín, Brenda Bautista Martínez. Caminos fisiopatológicos y blancos terapéuticos actuales para nefropatía diabética en diabetes tipo 1 y 2. Acta Médica Grupo Ángeles 2025; 23(1) doi: 10.35366/119347
|
| 40 |
Tarun Dua, Swarnalata Joardar, Pratik Chakraborty, Shovonlal Bhowmick, Achintya Saha, Vincenzo De Feo, Saikat Dewanjee. RETRACTED: Myricitrin, a Glycosyloxyflavone in Myrica esculenta Bark Ameliorates Diabetic Nephropathy via Improving Glycemic Status, Reducing Oxidative Stress, and Suppressing Inflammation. Molecules 2021; 26(2) doi: 10.3390/molecules26020258
|
| 41 |
Leiming Sun, Zheng Yang, Jiaying Zhang, Jie Wang. Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats. Bioengineered 2021; 12(2) doi: 10.1080/21655979.2021.2006978
|
| 42 |
Jing Ji, Pengyu Tao, Qian Wang, Lingxing Li, Yuzhen Xu. SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(5) doi: 10.2174/1871530320666201029143606
|
| 43 |
Elinor C. Mannon, Paul M. O’Connor. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?. American Journal of Physiology-Renal Physiology 2020; 319(6) doi: 10.1152/ajprenal.00343.2020
|
| 44 |
Semwal Bhupesh, Neha Chauhan, Verma Jyoti, Kumar Ankit, Singh Sonia, Singh Bhupendra. A Narrative Review of Signaling Pathway and Treatment Options for Diabetic Nephropathy. Current Molecular Medicine 2025; 25(2) doi: 10.2174/1566524023666230727093911
|
| 45 |
Delessa Hirpa, Bilisuma Girma. Burden and Predictors of Diabetic Nephropathy in an Adult With Diabetes Mellitus Patients on Follow up at Ambo University Referral Hospital Central Ethiopia. Qeios 2024; doi: 10.32388/2VCC0D
|
| 46 |
Arianna Scala, Ilaria Loperto, Rosa Carrano, Stefano Federico, Maria Triassi, Giovanni Improta. Assessment of proteinuria level in nephrology patients using a machine learning approach. 2021 5th International Conference on Medical and Health Informatics 2021; doi: 10.1145/3472813.3472816
|
| 47 |
Mohammad Reza Taherian, Koorosh Etemad, Soheila Sadeghi, Goljamal Jorjani, Seyed Saeed Hashemi Nazari, Huantian Cui. Diabetes Care Disparities: The Impact of Lifestyle, Medication Access, and Medical Conditions on Glycemic Control in Rural and Urban Settings. Journal of Diabetes Research 2025; 2025(1) doi: 10.1155/jdr/8029111
|
| 48 |
Langeswaran Kulanthaivel, Geevaprabhakaran Ganesan, Chandrashekar Kirubhanand, Gowtham Kumar Subbaraj. Advances in Diabetes Research and Management. 2023; doi: 10.1007/978-981-19-0027-3_5
|
| 49 |
Esrafil Mansouri, Mahmoud Orazizadeh, Seyyed Ali Mard, Armita Valizadeh Gorji, Mohammad Rashno, Fereshtesadat Fakhredini. Therapeutic Effect of Kidney Tubular Cells-Derived Conditioned Medium on the Expression of MicroRNA-377, MicroRNA-29a, Aquapurin-1, Biochemical, and Histopathological Parameters Following Diabetic Nephropathy Injury in Rats. Advanced Biomedical Research 2022; 11(1) doi: 10.4103/abr.abr_375_21
|
| 50 |
Martin Berger, Katharina Schütt. Kardiorenale Risikoreduktion bei Diabetes. Die Diabetologie 2023; 19(8) doi: 10.1007/s11428-023-01090-9
|
| 51 |
Renata Libianto, Duygu Batu, Richard J. MacIsaac, Mark E. Cooper, Elif I. Ekinci. Pathophysiological Links Between Diabetes and Blood Pressure. Canadian Journal of Cardiology 2018; 34(5) doi: 10.1016/j.cjca.2018.01.010
|
| 52 |
Chia-Lin Lee, Cheng-Hsu Chen, Ming-Ju Wu, Shang-Feng Tsai. The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes. Therapeutic Advances in Chronic Disease 2020; 11 doi: 10.1177/2040622319898370
|
| 53 |
Merita Rroji, Goce Spasovski. Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030657
|
| 54 |
Radmila Žeravica, Branislava Ilinčić, Dragan Burić, Ana Jakovljević, Veljko Crnobrnja, Dalibor Ilić, Marija Vukmirović Papuga. Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology. International Journal of Molecular Sciences 2024; 25(20) doi: 10.3390/ijms252011159
|
| 55 |
You Wang, Yuan Wang, Pei Pi, Dan Luo, Min Ning, Gang Ye. MiR-203 improved renal cell injury in diabetic nephropathy by targeting SOCS6/SOCS7 and inhibiting JAK/STAT pathway activation. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-95952-5
|
| 56 |
Yan Shen, Lianghua Xie, Xiangjun Chen, Lina Mao, Yao Qin, Rui Lan, Shumin Yang, Jinbo Hu, Xue Li, Hanwen Ye, Wenjin Luo, Lilin Gong, Qifu Li, Yun Mao, Zhihong Wang. Renal fat fraction is significantly associated with the risk of chronic kidney disease in patients with type 2 diabetes. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.995028
|
| 57 |
Xiaowen Pan, Xiling Lin, Xin Huang, Jingya Xu, Lingxia Ye, Tianyue Zhang, Shaoning Hu, Hongwei Jiang, Yuezhong Ren, Peng-Fei Shan. The Burden of Diabetes-Related Chronic Kidney Disease in China From 1990 to 2019. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.892860
|
| 58 |
David Z. I. Cherney, Alan Bell, Louis Girard, Philip McFarlane, Louise Moist, Sharon J. Nessim, Steven Soroka, Sara Stafford, Andrew Steele, Navdeep Tangri, Jordan Weinstein. Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care. Canadian Journal of Kidney Health and Disease 2023; 10 doi: 10.1177/20543581221150556
|
| 59 |
Hsiao‐Ling Chen, I‐Ting Wang, Yi‐Wen Tsai, Yu‐Hsuan Lee, Chen‐Huan Chen, Chern‐En Chiang, Hao‐Min Cheng. Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study. Diabetes, Obesity and Metabolism 2025; 27(1) doi: 10.1111/dom.15998
|
| 60 |
Jacob Bar-Tana. Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Reviews in Endocrine and Metabolic Disorders 2020; 21(4) doi: 10.1007/s11154-020-09545-w
|
| 61 |
Nancy Helou, Dominique Talhouedec, Maya Zumstein-Shaha, Anne Zanchi. A Multidisciplinary Approach for Improving Quality of Life and Self-Management in Diabetic Kidney Disease: A Crossover Study. Journal of Clinical Medicine 2020; 9(7) doi: 10.3390/jcm9072160
|
| 62 |
Phil McEwan, Rebecca Boyce, Juan Jose Garcia Sanchez, C David Sjöström, Bergur Stefansson, Stephen Nolan, Ricardo Correa-Rotter, Peter Rossing, Glenn M Chertow, John J V McMurray, David C Wheeler, Hiddo J L Heerspink. Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis. Nephrology Dialysis Transplantation 2023; 38(5) doi: 10.1093/ndt/gfac280
|
| 63 |
Tianxiao Zhang, Xiaodan Wang, Yueying Zhang, Ying Yang, Congying Yang, Huiyi Wei, Qingbin Zhao. Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04245-w
|
| 64 |
Deodatta Chafekar. Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation. World Journal of Nephrology 2025; 14(1): 101515 doi: 10.5527/wjn.v14.i1.101515
|
| 65 |
Raphaëlle Corremans, Benjamin A. Vervaet, Geert Dams, Patrick C. D’Haese, Anja Verhulst. Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24109043
|
| 66 |
Siti Aisyah Ramli, Nani Draman, Juliawati Muhammad, Siti Suhaila Mohd Yusoff. Diabetes self-care and its associated factors among type 2 diabetes mellitus with chronic kidney disease patients in the East Coast of Peninsular Malaysia. PeerJ 2024; 12 doi: 10.7717/peerj.18303
|
| 67 |
Martin Haluzík, Alice Cheng, Dirk Müller‐Wieland, Jukka Westerbacka, Zsolt Bosnyak, Felipe Lauand, Lydie Melas‐Melt, Janaka Karalliedde, Julio Rosenstock, Geremia B. Bolli. Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial. Diabetes, Obesity and Metabolism 2020; 22(8) doi: 10.1111/dom.14043
|
| 68 |
Chelsy L. Cliff, Bethany M. Williams, Christos E. Chadjichristos, Ulrik Mouritzen, Paul E. Squires, Claire E. Hills. Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes. International Journal of Molecular Sciences 2022; 23(2) doi: 10.3390/ijms23020600
|
| 69 |
Holly J. Kramer, Shivam Joshi. Nutritional Management of Renal Disease. 2022; doi: 10.1016/B978-0-12-818540-7.00028-8
|
| 70 |
Delessa Hirpa, Bilisuma Girma. Burden and Predictors of Diabetic Nephropathy in an Adult With Diabetes Mellitus Patients on Follow up at Ambo University Referral Hospital Central, Ethiopia. Qeios 2024; doi: 10.32388/2VCC0D.2
|
| 71 |
Rongrong Deng, Kaiying He, Qicai You, Wenkai Zhang, Xuezhen Ma, Xiaochun Zhou, Yuke Kong, Jianqin Wang. CLCF1 contributes to high-glucose-induced EndMT by modulating JAK2/STAT3 signaling. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02932-6
|
| 72 |
Yi Chen, Li Chen, Taiwang Yang. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119197
|
| 73 |
Ilaria Loperto, Arianna Scala, Lucia Rossano, Rosa Carrano, Stefano Federico, Maria Triassi, Giovanni Improta. Use of regression models to predict glomerular filtration rate in kidney transplanted patients. 2021 International Symposium on Biomedical Engineering and Computational Biology 2021; doi: 10.1145/3502060.3503627
|
| 74 |
Nida Baig, Rabia Sultan, Shamim Akhtar Qureshi. Antioxidant and anti-inflammatory activities of Centratherum anthelminticum (L.) Kuntze seed oil in diabetic nephropathy via modulation of Nrf-2/HO-1 and NF-κB pathway. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03776-x
|
| 75 |
Maolin Zhu, Huiyang Wang, Jiawei Chen, Huang Zhu. Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats. Life Sciences 2021; 265 doi: 10.1016/j.lfs.2020.118855
|
| 76 |
Vageesh Ayyar, Tittu Ommen, R. P. Shukla, Anish Ahmed, Sahil Fulara, Aushili Mahule, Ashish Prasad, Abhijit Pednekar. Synergizing sodium-dependent glucose transporter inhibitors with dipeptidyl-peptidase 4 inhibitor and metformin: a novel approach to diabetes management in Indi. International Journal of Basic & Clinical Pharmacology 2025; doi: 10.18203/2319-2003.ijbcp20250018
|
| 77 |
Niloufar Torkamani, George Jerums, Paul Crammer, Alison Skene, David A. Power, Sianna Panagiotopoulos, Michele Clarke, Richard J. MacIsaac, Elif I. Ekinci. Three Dimensional Glomerular Reconstruction: A Novel Approach to Evaluate Renal Microanatomy in Diabetic Kidney Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-38646-z
|
| 78 |
Hiroki Tsuchida, Hiroyuki Suda, Yoko Tsuchiya, Kiyoaki Iwashita, Naotake Hashimoto. Metabolic syndrome nephropathy: A retrospective study of the rate of diagnosis, clinical progression, and relationship to systemic arteriosclerosis. Vascular Failure 2024; 8(1) doi: 10.30548/vascfail.8.1_7
|
| 79 |
Kyunghun Sung, Jae-Seung Yun, Bongseong Kim, Hun-Sung Kim, Jae-Hyoung Cho, Yong-Moon Mark Park, Kyungdo Han, Seung-Hwan Lee. Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study. Diabetes & Metabolism Journal 2025; 49(4) doi: 10.4093/dmj.2024.0578
|
| 80 |
Adrian Liew, Sunita Bavanandan, Chuan‐Ming Hao, Soo Kun Lim, Narayan Prasad, Manisha Sahay, Paweena Susantitaphong, Veena Roberts, Eranga Wijewickrama, Muh Geot Wong, Sydney C. W. Tang. Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update. Nephrology 2025; 30(S2) doi: 10.1111/nep.70030
|
| 81 |
Sanjana Datla, Zainab Albar, Elke Eaton, Jodie Porges, Matthew Nennstiel, Claire Sullivan, Lloyd Greene, Sadeer G. Al-Kindi, Elizabeth Montgomery, Aparna Padiyar, Mikhail Kosiborod, Melissa L. Magwire, Mahboob Rahman, Sanjay Rajagopalan, Ian J. Neeland. Chronic kidney disease prevalence and outcomes in patients with type 2 diabetes or prediabetes at high cardiovascular risk: results from the CINEMA program. American Journal of Preventive Cardiology 2025; 22 doi: 10.1016/j.ajpc.2025.101004
|
| 82 |
Anna M. Drake, Melinda T. Coughlan, Claus T. Christophersen, Matthew Snelson. Resistant Starch as a Dietary Intervention to Limit the Progression of Diabetic Kidney Disease. Nutrients 2022; 14(21) doi: 10.3390/nu14214547
|
| 83 |
Ping Lai, Xiaoyan Gu, Xuhui Lin, Yu He, Yining Dai, Chongyang Duan, Yuanhui Liu, Wenfei He. Association of random glucose to albumin ratio with post-contrast acute kidney injury and clinical outcomes in patients with ST-elevation myocardial infarction. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1390868
|
| 84 |
Teerawat Thanachayanont, Methee Chanpitakkul, Jukkapong Hengtrakulvenit, Podjanee Watcharakanon, Watcharapong Wisansak, Teerapong Tancharoensukjit, Phosri Kaewsringam, Vinai Leesmidt, Krit Pongpirul, Salyaveth Lekagul, Kriang Tungsanga. Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT‐2) trials. Nephrology 2021; 26(4) doi: 10.1111/nep.13849
|
| 85 |
Devin Clark, Taylor Mattice, M. Jennifer Abuzzahab, Petter Bjornstad, Amanda Nickel, Shea Lammers, Anupam Kharbanda, Kelly R. Bergmann. Hyperkalemia During Diabetic Ketoacidosis and the Association With Acute Kidney Injury. Pediatrics Open Science 2025; 1(1) doi: 10.1542/pedsos.2024-000251
|